Visual and Refractive Outcomes of Small Incision Lenticule Extraction With VisuMax 800 in 1,500 Eyes.

IF 3 3区 医学 Q1 OPHTHALMOLOGY
Sri Ganesh, Supriya Samak Sriganesh, Dhatri Karanam
{"title":"Visual and Refractive Outcomes of Small Incision Lenticule Extraction With VisuMax 800 in 1,500 Eyes.","authors":"Sri Ganesh, Supriya Samak Sriganesh, Dhatri Karanam","doi":"10.3928/1081597X-20250707-04","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To assess visual and refractive outcomes of 1,500 eyes that underwent small incision lenticule extraction (SMILE) with the VisuMax 800 femtosecond laser (Carl Zeiss Meditec AG).</p><p><strong>Methods: </strong>This retrospective study includes 1,500 eyes of 770 patients younger than 45 years with corrected distance visual acuity (CDVA) of 20/20 or better who were treated with SMILE using the VisuMax 800. The surgery was performed by an experienced surgeon using a standard technique and 3-month follow up data were analyzed.</p><p><strong>Results: </strong>A total of 1,500 eyes of patients with a mean age of 27.25 ± 4.746 years (39.5% men and 60.52% women) were included in this study. At 3 months, 98% of eyes had uncorrected distance visual acuity (UDVA) of 20/20 or better with an efficacy index of 1.011. Mean preoperative spherical equivalent (SE) was -4.170 ± 1.860 and -0.025 ± 0.120 diopters (D) at 3 months (<i>P</i> < .001). A total of 18.4% gained one line of CDVA and 9.2% lost one line with a safety index of 1.085. Postoperative SE was within ±0.50 and ±1.00 D in 99% and 100% of eyes, respectively. A total of 98.4% and 100% of eyes showed astigmatism of 0.50 and 1.00 D or less, respectively. No eyes lost two or more lines of CDVA. At 3 months, the Objective Scatter Index score was 0.844 ± 0.486, which was close to preoperative values (0.733 ± 0.871), with a mean change of 0.11. Subgroup analysis was done based on grade of myopia and age.</p><p><strong>Conclusion: </strong>The VisuMax 800, with centration guidance (CentraLign) and cyclotorsion adjustment features (OcuLign), showed safe and effective outcomes for the treatment of myopia and myopic astigmatism in a large cohort of 1,500 eyes.</p>","PeriodicalId":16951,"journal":{"name":"Journal of refractive surgery","volume":"41 10","pages":"e1049-e1059"},"PeriodicalIF":3.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of refractive surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/1081597X-20250707-04","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To assess visual and refractive outcomes of 1,500 eyes that underwent small incision lenticule extraction (SMILE) with the VisuMax 800 femtosecond laser (Carl Zeiss Meditec AG).

Methods: This retrospective study includes 1,500 eyes of 770 patients younger than 45 years with corrected distance visual acuity (CDVA) of 20/20 or better who were treated with SMILE using the VisuMax 800. The surgery was performed by an experienced surgeon using a standard technique and 3-month follow up data were analyzed.

Results: A total of 1,500 eyes of patients with a mean age of 27.25 ± 4.746 years (39.5% men and 60.52% women) were included in this study. At 3 months, 98% of eyes had uncorrected distance visual acuity (UDVA) of 20/20 or better with an efficacy index of 1.011. Mean preoperative spherical equivalent (SE) was -4.170 ± 1.860 and -0.025 ± 0.120 diopters (D) at 3 months (P < .001). A total of 18.4% gained one line of CDVA and 9.2% lost one line with a safety index of 1.085. Postoperative SE was within ±0.50 and ±1.00 D in 99% and 100% of eyes, respectively. A total of 98.4% and 100% of eyes showed astigmatism of 0.50 and 1.00 D or less, respectively. No eyes lost two or more lines of CDVA. At 3 months, the Objective Scatter Index score was 0.844 ± 0.486, which was close to preoperative values (0.733 ± 0.871), with a mean change of 0.11. Subgroup analysis was done based on grade of myopia and age.

Conclusion: The VisuMax 800, with centration guidance (CentraLign) and cyclotorsion adjustment features (OcuLign), showed safe and effective outcomes for the treatment of myopia and myopic astigmatism in a large cohort of 1,500 eyes.

VisuMax 800小切口晶状体摘除术1500眼视力及屈光效果观察。
目的:评估使用VisuMax 800飞秒激光(卡尔蔡司Meditec AG)进行小切口晶状体摘除术(SMILE)的1500只眼睛的视力和屈光结果。方法:采用VisuMax 800进行SMILE治疗的年龄小于45岁、矫正距离视力(CDVA)为20/20及以上的患者770例,1500只眼进行回顾性研究。手术由经验丰富的外科医生使用标准技术进行,并对3个月的随访数据进行分析。结果:纳入患者1500只眼,平均年龄27.25±4.746岁,其中男性占39.5%,女性占60.52%。3个月时,98%的眼未矫正距离视力(UDVA)在20/20及以上,疗效指数为1.011。术前3个月平均球面等效度(SE)分别为-4.170±1.860和-0.025±0.120屈光度(D) (P < 0.001)。CDVA上涨1条线的占18.4%,下跌1条线的占9.2%,安全指数为1.085。99%和100%的眼睛术后SE分别在±0.50和±1.00 D以内。散光≤0.50 D的占98.4%,小于1.00 D的占100%。没有眼睛失去两行或更多的CDVA。3个月时,客观散射指数评分为0.844±0.486,与术前值(0.733±0.871)接近,平均变化0.11。根据近视程度和年龄进行亚组分析。结论:VisuMax 800具有聚焦引导(CentraLign)和旋扭调节功能(OcuLign),在1500只眼的大队列研究中显示出安全有效的治疗近视和近视散光的效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.10
自引率
12.50%
发文量
160
审稿时长
4-8 weeks
期刊介绍: The Journal of Refractive Surgery, the official journal of the International Society of Refractive Surgery, a partner of the American Academy of Ophthalmology, has been a monthly peer-reviewed forum for original research, review, and evaluation of refractive and lens-based surgical procedures for more than 30 years. Practical, clinically valuable articles provide readers with the most up-to-date information regarding advances in the field of refractive surgery. Begin to explore the Journal and all of its great benefits such as: • Columns including “Translational Science,” “Surgical Techniques,” and “Biomechanics” • Supplemental videos and materials available for many articles • Access to current articles, as well as several years of archived content • Articles posted online just 2 months after acceptance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信